Actionable news
0
All posts from Actionable news
Actionable news in RXII: RXI PHARMACEUTICALS CORPORATION,

Neonode Announces Pricing of Public Offering of Common Stock

STOCKHOLM, Oct. 07, 2015 (GLOBE NEWSWIRE) -- Neonode Inc. (NEON) (“Neonode” or the “Company”) today announced the pricing of an underwritten public offering of 3,200,000 shares of common stock of the Company at a price to the public of $1.90 per share. The offering is expected to close on or about October 13, 2015, subject to the satisfaction of customary closing conditions.

Per Bystedt (Chairman), Thomas Eriksson (Chief Executive Officer), and Mats Dahlin, members of Neonode’s Board of Directors, intend to purchase an aggregate of $300,000 of shares of common stock from the underwriter in the offering at the public offering price per share.

Gross proceeds to the Company from the offering are expected to be approximately $6.1 million. Neonode anticipates using its net proceeds from the offering primarily for general corporate purposes, including capital expenditures and working capital.

Craig-Hallum Capital Group LLC acted as the sole book-running manager for the offering.

The securities described above are being offered pursuant to an effective shelf registration statement previously filed by Neonode with the Securities and Exchange Commission (the “SEC”). The securities may be offered only by means of a prospectus. Copies of the final prospectus supplement and the accompanying prospectus relating to this offering, when available, will be available on the SEC’s website located at http://www.sec.gov and...


More